MOUNT PLEASANT, S.C., Sept. 27 /PRNewswire-FirstCall/ -- Maxxon, Inc. (“Maxxon”), a growing medical products designer, manufacturer, and distributor concentrating on innovative safety devices which will have a price advantage over many competitors in the medical products arena, is pleased to announce that a patent for its Vacuum Operated ReVac Safety Syringe has been filed.
The new patent for the vacuum operated safety syringe was filed on Sept. 21, 2005 by patent Attorney Richard Moseley. Maxxon, Inc. and Globe Medical Tech shall each share 50% of the new patent.
The new patent covers another area of breakthrough technology. The relatively smaller cross section of the plunger, as compared to the barrel, produces a greater corresponding vacuum force to retract the used needle into the barrel. The new invention may also apply to various syringe sizes, shapes and different clinical applications. The applications in the evaluation and design phase include Vacuum Operated Retractable IV Catheter and Butterfly set.
Ron Wheet, CEO of Maxxon, stated, “Our patent uses ‘FREE AIR’ as the catalyst for needle retraction and has many advantages over our competitors, who are currently using a steel spring as the force to pull the used needle into the barrel. Their design increases manufacturing complexity, has a higher defective rate and forces the cost to swell.”
“I believe the inherent advantages in the Vacuum Operated ReVac Safety Syringe will help the product garner attention, plus the low cost should allow market penetration in markets that other retractable safety syringes can’t touch,” added Andy Hu, CTO of Maxxon.
About Maxxon
Maxxon recently entered into a 50/50 Joint Venture, with Globe Med Tech, to produce and/or distribute several new safety medical products including its ReVac Safety Syringe, Auto Retractable Safety Scalpel with Permanent Lock, and the Auto Retractable Safety IV. Several of the patented products use vacuum force to operate automatic retractable technology. The company feels that it will be able to market itself as a growing medical products designer, manufacturer and distributor that creates innovative devices which it believes will have a price advantage over its competitors in the safety medical products arena.
Maxxon’s 3 cc safety syringe is designed as a single-handed, vacuum- operated safety syringe that retracts the used needle into the syringe after use. For more information on Maxxon, please go to http://www.maxxoninc.com .
About Globe Medical Tech
Globe Medical Tech, Inc. is a high-tech medical safety and drug delivery products developer and manufacturer based in Houston, Texas, with a clean-room manufacturing presence in China. Globe has marketed its products in the U.S. and around the world, providing the medical industry with innovative low-cost, high-quality medical products. Globe’s team has accumulated valuable integration experience for medical devices, while establishing itself as a cost effective operator in the medical device industry. Whether under the company’s brand name, or under a private label, Globe has a history of effectively integrating patent development, research, and engineering design capabilities. For more information on Globe, please go to http://www.globemedtech.com .
This press release contains some forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in Maxxon’s SEC filings.
Maxxon, Inc. Brian Heckathorne (866) 288-0033 brian@idmcorp.us
Maxxon, Inc.
CONTACT: Brian Heckathorne of Maxxon, Inc., +1-866-288-0033, orbrian@idmcorp.us